Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02423525
Title Safety Study of Afatinib for Brain Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Diego
Indications

malignant leptomeningeal tumor

mixed oligodendroglioma-astrocytoma

malignant astrocytoma

oligodendroglioma

meningioma

high grade glioma

glioblastoma

Therapies

Afatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.